Document is current

Any future updates will be listed below

Efficacy of omalizumab (Xolair®) in patients with moderate to severe predominately chronic oral steroid dependent asthma in Taiwan: a retrospective, population-based database cohort study

Crossref DOI link: https://doi.org/10.1186/s12890-015-0156-2

Published Online: 2016-01-08

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark